title: PHARMAC responds on long-acting inhalers for COPD.
authors.forename: Scott
authors.initials: S
authors.lastname: Metcalfe
authors.forename: Sean
authors.initials: S
authors.lastname: Dougherty
mesh_terms: D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D001249:Asthma; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D017277:Drug Approval; D004341:Drug Evaluation / Q000379:methods; D006801:Humans; D009313:National Health Programs / Q000458:organization & administration; D009520:New Zealand; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012602:Scopolamine Derivatives / Q000008:administration & dosage; D000069447:Tiotropium Bromide; D016896:Treatment Outcome
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide